Contemporaneous Presentation of Ocular Myasthenia Gravis With Pituitary Apoplexy: A Diagnostic Dilemma

Pituitary apoplexy is a life-threatening condition caused by a rapid expansion of the pituitary tumor due to hemorrhage or infarction. It usually presents with acute onset severe headache and can also be associated with visual field defects and ophthalmoplegia. Similarly, ocular myasthenia gravis, which is an autoimmune condition causing muscle fatiguability, also presents with ophthalmoplegia, commonly ptosis and diplopia. A 53-year-old male patient with a past history of adrenal insufficiency presented with acute onset headache. On examination, he had bilateral asymmetrical partial ptosis and left-side medial rectus palsy with mild fatiguability. He had normal visual fields and sparing of the pupils. Acetylcholine receptor antibodies were positive but failed to demonstrate a decremental response in nerve conduction studies. The patient was started on neostigmine on clinical suspicion of ocular myasthenia gravis. A magnetic resonance imaging (MRI) scan of the brain was arranged to look for any intracranial pathology for persistent headache and it revealed evidence of pituitary apoplexy with compression of optic chiasm and partial obliteration of bilateral cavernous sinuses. In view of MRI findings, a diagnosis of pituitary apoplexy with third cranial nerve involvement was considered the first differential diagnosis, and the patient was started on replacement hormones while temporarily withholding neostigmine. Following multidisciplinary input, it was decided to manage the patient conservatively. A repeat MRI brain was planned to assess the evolution which revealed resolution of pituitary apoplexy. Despite this, the patient continued to have ophthalmoplegia and fatigable partial ptosis. Pyridostigmine was restarted following which the patient fully recovered, confirming the diagnosis of ocular myasthenia gravis presenting concomitantly with pituitary apoplexy.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-03-16
DOI
https://doi.org/10.7759/cureus.80666
Primary Topic
Pituitary Gland Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Contemporaneous Presentation of Ocular Myasthenia Gravis With Pituitary Apoplexy: A Diagnostic Dilemma

KVC Janaka, Dimithri Gamaarachchi, H.A.C.K. Rathnayake, Hiruni Fernando et al.
Cureus
Pituitary Gland Disorders and Treatments
article

Contemporaneous Presentation of Ocular Myasthenia Gravis With Pituitary Apoplexy: A Diagnostic Dilemma

KVC Janaka, Dimithri Gamaarachchi, H.A.C.K. Rathnayake, Hiruni Fernando, Isuru Perera
article en

Abstract

Pituitary apoplexy is a life-threatening condition caused by a rapid expansion of the pituitary tumor due to hemorrhage or infarction. It usually presents with acute onset severe headache and can also be associated with visual field defects and ophthalmoplegia. Similarly, ocular myasthenia gravis, which is an autoimmune condition causing muscle fatiguability, also presents with ophthalmoplegia, commonly ptosis and diplopia. A 53-year-old male patient with a past history of adrenal insufficiency presented with acute onset headache. On examination, he had bilateral asymmetrical partial ptosis and left-side medial rectus palsy with mild fatiguability. He had normal visual fields and sparing of the pupils. Acetylcholine receptor antibodies were positive but failed to demonstrate a decremental response in nerve conduction studies. The patient was started on neostigmine on clinical suspicion of ocular myasthenia gravis. A magnetic resonance imaging (MRI) scan of the brain was arranged to look for any intracranial pathology for persistent headache and it revealed evidence of pituitary apoplexy with compression of optic chiasm and partial obliteration of bilateral cavernous sinuses. In view of MRI findings, a diagnosis of pituitary apoplexy with third cranial nerve involvement was considered the first differential diagnosis, and the patient was started on replacement hormones while temporarily withholding neostigmine. Following multidisciplinary input, it was decided to manage the patient conservatively. A repeat MRI brain was planned to assess the evolution which revealed resolution of pituitary apoplexy. Despite this, the patient continued to have ophthalmoplegia and fatigable partial ptosis. Pyridostigmine was restarted following which the patient fully recovered, confirming the diagnosis of ocular myasthenia gravis presenting concomitantly with pituitary apoplexy.

CureusVol. 17(3)
University of Sri Jayewardenepura (LK)
Good health and well-being
Openalex Percentile: Top 93%
Pituitary Gland Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Contemporaneous Presentation of Ocular Myasthenia Gravis With Pituitary Apoplexy: A Diagnostic Dilemma — KVC Janaka, Dimithri Gamaarachchi, et al. · Cureus (2025) | TGRS Research Map | TGRS